We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




New PET Offers Improved Imaging and Reconstruction Technology

By HospiMedica International staff writers
Posted on 30 Oct 2013
New positron emission tomography (PET) image reconstruction technology has been designed to provide better image quality, reduced acquisition time, and lower injected agent dose. More...
Current PET iterative reconstruction technologies, such as time-of-flight (TOF) and ordered subset expectation maximization (OSEM), are not able to control noise when the number of iterations increases, which leads to a trade-off of quantitative accuracy in favor of image quality.

When determining if a specific cancer treatment is effective, clinicians not only want to identify the smallest of lesions, but also the capability of determining earlier whether the metabolic activity is being mitigated under current treatment. For accurate treatment response evaluation, a clinician requires accurate quantitative applications. GE Healthcare’s GE Healthcare (Chalfont St. Giles, UK) Q.Suite tools demonstrate the importance of eliminating variability such as respiratory motion. Q.Suite enables clinicians to evaluate treatment response more accurately than ever before, enabling them to effectively assess biologic changes in a patient during course of treatment.

GE Healthcare presented the Q.Suite T Imaging and Reconstruction tools at the 2013 European Association of Nuclear Medicine Congress (EANM), held October 2013 in Lyon (France). GE Healthcare’s interactive educational experience on PET regularized reconstruction technology presented at the Congress showed what is possible when forcing a choice between image quality or quantitation accuracy is no longer necessary.

PET regularized reconstruction technology that was displayed at EANM interactively shows the potential of full convergence PET imaging. “We know that cancer patients don’t always respond to their initial course of treatment,” said Steve Gray, president and CEO of GE Healthcare’s MICT (multiple image computed tomography) business. “If we can give clinicians a more accurate, reliable, and faster tool to confirm that a change in treatment is needed, the patient will benefit greatly. For example, PET/CT can help clinicians determine whether chemotherapy is working after as few as one to two cycles, saving patient’s unnecessary procedures and a significant amount of money.”

Related Links:

GE Healthcare



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Infant Incubator
OKM 801
Gynecological Examination Chair
arco-matic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.